Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryoport (CYRX) EBIT (2016 - 2026)

Cryoport has reported EBIT over the past 17 years, most recently at -$9.6 million for Q1 2026.

  • Quarterly EBIT fell 33.64% to -$9.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$9.2 million through Mar 2026, up 20.9% year-over-year, with the annual reading at -$6.8 million for FY2025, 69.17% up from the prior year.
  • EBIT was -$9.6 million for Q1 2026 at Cryoport, down from $20.0 million in the prior quarter.
  • Over five years, EBIT peaked at $87.0 million in Q4 2024 and troughed at -$78.0 million in Q2 2024.
  • The 5-year median for EBIT is -$9.6 million (2025), against an average of -$5.2 million.
  • Year-over-year, EBIT plummeted 584.68% in 2022 and then surged 350.13% in 2023.
  • A 5-year view of EBIT shows it stood at -$11.0 million in 2022, then surged by 350.13% to $27.6 million in 2023, then soared by 215.24% to $87.0 million in 2024, then crashed by 76.99% to $20.0 million in 2025, then plummeted by 148.02% to -$9.6 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's EBIT are -$9.6 million (Q1 2026), $20.0 million (Q4 2025), and -$9.9 million (Q3 2025).